Direkt zum Inhalt
Merck

Oral insulin delivery by means of solid lipid nanoparticles.

International journal of nanomedicine (2008-01-22)
Bruno Sarmento, Susana Martins, Domingos Ferreira, Eliana B Souto
ZUSAMMENFASSUNG

The aim of this work was to produce and characterize cetyl palmitate-based solid lipid nanoparticles (SLN) containing insulin, and to evaluate the potential of these colloidal carriers for oral administration. SLN were prepared by a modified solvent emulsification-evaporation method based on a w/o/w double emulsion. The particle size, zeta potential and association efficiency of unloaded and insulin-loaded SLN were determined and were found to be around 350 nm, negatively charged and the insulin association efficiency was over 43%. After oral administration of insulin-loaded SLN to diabetic rats, a considerable hypoglycemic effect was observed during 24 hours. These results demonstrated that SLN promote the oral absorption of insulin.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Palmitinsäure-palmitylester, ≥99%
Supelco
Cetylpalmitat, Pharmaceutical Secondary Standard; Certified Reference Material